The following is a guided tour through the original XMRV study conducted by the following personnel.
I have added some contextual information and punctuation where I think appropriate to facilitate understanding
Vincent C. Lombardi, 1* Francis W. Ruscetti, 2* Jay dip Das Gupta, 3 Max A. Pfost, 1
Kathryn S. Hagen, 1 Daniel L. Peterson, 1 Sandra K. Ruscetti, 4 Rachel K. Bagni, 5
Cari Petrow-Sadowski, 6 Bert Gold, 2 Michael Dean, 2 Robert H. Silverman, 3 Judy A. Mikovits1†
This is the cohort information that seems to cause so much confusion:
“Banked samples were selected for this study from patients fulfilling the 1994 C.D.C. Fukuda Criteria for Chronic Fatigue Syndrome (S1) AND
The 2003 Canadian Consensus Criteria for Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) and presenting with severe disability.
These are patients that have been seen in private medical practices, and their diagnosis of CFS is based upon prolonged disabling fatigue and the presence of cognitive deficits and reproducible immunological abnormalities. These included but were not limited to perturbations of the 2-5A synthetase / RNase L antiviral pathway, low natural killer cell cytotoxicity (as measured by standard diagnostic assays), and elevated cytokines particularly interleukin-6 and interleukin-8. In addition to these immunological abnormalities, the patients characteristically demonstrated impaired exercise performance with extremely low VO2 max measured on stress testing. The patients had been seen over a prolonged period of time and multiple longitudinal observations of the clinical and laboratory abnormalities had been documented.”
Note the objective criteria for diagnosis and the MEASURED impairment of Vo2. I struggle to see why experienced people can’t see that this is a different patient cohort to the English studies. If I am reading the above correctly then ALL patients satisfied the Canadian and the FUKUDA criteria.
I have written seeking confirmation
It is important to remember that the paper consists of quite separate experiments.
Here is the first one:
DNA and RNA isolation.
Whole blood was drawn from subjects. The blood was fresh not frozen.
“PBMC were isolated by layering the diluted blood onto Ficoll-Paque PLUS (GE Healthcare, Waukesha, WI), centrifuging for 22 min at 800 g, aspirating the PBMC layer and washing it once in PBS. The PBMC (approximately 2 x 107 cells) were centrifuged at 500x g for 7 min and either stored as unactivated cells in 90% FBS and 10% DMSO at -80 C for further culture and analysis or resuspended in TRIzol (Invitrogen, Carlsbad, CA) and stored at -80 C for DNA and RNA extraction and analysis.”
Note the unactivated PMBCs were frozen for culture and further experiments
OR
resuspended in Trizol for nucleic acid extraction OR further experimentation
“PCR methodology on extracted DNA
PCR. To avoid potential problems with laboratory DNA contamination, nested PCR was performed with separate reagents in a separate laboratory room designated to be free of high copy amplicon or plasmid DNA. Negative controls in the absence of added DNA were included in every experiment.
Identification of XMRV gag and env genes was performed by PCR in separate reactions.
PCR amplification for sequencing full-length XMRV genomes was
performed on DNA amplified by nested or semi-nested PCR
PCR analysis performed on 20 of the identical patient PBMC DNA
specimens stored at the NCI (Frederick, MD) since 2007 confirmed nearly identical gag sequences, thereby diminishing the possibility of laboratory contamination as a source of XMRV”
This dealt with the issue of contamination and replicated the findings of this part of the experiment.
It is important to note that PCR was the approach taken in the Imperial college and Groom studies. The claim that the PCR methodology needed validation is objectively false. It had already been achieved by an independent laboratory.
“Nested RT-PCR for gag sequences was done as described”
Neither the Imperial college study nor the Groom study even attempted to do this despite looking for a RNA virus. RT –PCR looks for viral RNA. You don’t need replicating virus for this test but you do for PCR
Hence both studies based their approach on the assumption that the virus if present would be replicating.
The significance of the RT approach will be apparent in the conclusion.
The DNA extracted above was used to from the whole viral genome which was then compared to all other known Mulv viruses both exogenous and endogenous this was also done at the National cancer institute laboratory.The presence of all MuLV viruses were excluded during this analysis.
Both sets of researchers confirmed that the viral genome corresponded almost exactly with the VP^2 genome as produced by the original discoverers of the virus. The match was greater than 99.9%
Ok, good point for a summary
The FIRST experiment showed that there was a presence of XMRV gag and XMRV env in the sample of concentrated Peripheral mononuclear cells (PMBCs) taken from FRESH blood. The Viral DNA was sequenced and compared to all known MuLVs and was different to any. It was then compared to the DNA sequence of the original XMRV isolated and genotyped by the discoverers of XMRV and it was an almost perfect match. The PMBCs of patients diagnosed according to the criteria in the study contained XMRV DNA.
NEXT EXPERIMENT. All sections also contained controls using the same parameters isolated from healthy donors
Leucocytes (a kind of white blood cell) were isolated from the FROZEN PMBCs of patients and fresh PMBCs of healthy donors.
These were then activated (PHA).
They were then cultured for 42 days with sub-culturing taking place every 3 to 5 days.
That was the first amplification procedure.
CD4+ T and CD3+ T cells were isolated and further cultured.
That was the second amplification procedure
The CD4+T cells were further amplified and activated by culturing with IL2.
CD19+B cells were also isolated from the activated leucocytes and the concentration amplified by further culture.
Ok now we have hugely amplified concentrations of activated T and B cells to work with.
Bear in mind that the English studies not did not isolate PMBC cells from FROZEN blood and amplify them in any way. The concentrations of virus in this experiment were huge in comparison to the levels to be found directly from whole blood.
The next part of the experiment is divided into two parts:
[/e cultCOLOR]
The cultured T and B cells were separated from the medium they grew in (the supernatant).
The cells were broken up (lysed). The protein content was isolated (Flow cytometry and Western Blotting).
Protein products of gp55 env, gp70 env, p30gag and p10 gag. were identified.
Next step was to see if there was infectious virus.
Was the virus able to leave T and B cells and get into the supernatant
LnCap cells were cultured with the supernatant using an accelerated culture/ transfect ion investigating cellular infection and cell transfer.
The protein content of the LNCap cells was analysed as above and produced an exact match.
Nested PCR revealed the presence of XMRV gag.
Allele specific PCR revealed the presence of the XMRV genome VP62 which was the same sequence identified in experiment one.
Conclusion
There was infective XMRV present in the original PMBC’s from the CFS patients diagnosed by the criteria used in this study.
Experiment 3.
Plasma from 9 out of 18 cfs patients provided a specific response with SSFV-env.
Plasma also blocked the reaction between SSFV env and SSFV env Mab
Conclusions
XMRV mounts an immune response in plasma from patients with ME/CFS.
The possibility of the presence of other Mulvs had been excluded in experiment one. Hence no possibility of a cross reaction.
PCR Hit rates
Nested PCR on fresh blood PMBC’s 20% hit rate
This means that at this concentration of PMBC’s derived from 8 ml of fresh blood you would need to run a PCR assay 4 times to get a hit on viral RNA.
If you realise that McClure used 2 ml of frozen whole blood, then even if she had concentrated her sample she would have had to run her PCR 20 times to get one hit. Of course as the sample was much more dilute she would have had to run her assay many more times than that. There is a specific issue with the Groom samples which I will post at a later time.
RT-PCR on fresh blood pmbc isolates rate 50%. This is the one the English did not bother with at all. You need to run it twice to get a hit.
Nested PCR on amplified and activated PMB cells from FROZEN blood c90%
You virtually only have to run one PCR assay.
This is the point –if you want to try to isolate viral DNA from frozen blood then your chances are hugely improved if you isolate the target cells, activate them and expose them to multiple amplification procedures BEFORE PCR.